Companies / Argentina
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Tecnofarma Expands In Brazil, Boosts Output
September 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Latin American pharmaceutical group Tecnofarma is to expand its Zodiac unit in Brazil, spending some BRL12mn (US$5.6mn) on acquiring new brands in the oncology segment. The company is adding new products aimed at the US$350mn cancer sector to its portfolio, following successful licensing deals with Chiron and Hexal, both units of Switzerland's Novartis, as well as with US giant Pfizer. Zodiac's parent firm also expects to launch its first proprietary cancer drug in the